Pilot Study of Ultrasonic Determined Carotid Plaque Composition (UMP)
Ultrasonic Mapping of Carotid Plaque Composition
調査の概要
詳細な説明
Stroke is a major cause of morbidity and mortality among patients with cardiovascular disease and the major cause of long-term disability in the United States. Current imaging modalities can determine the severity of luminal stenosis resulting from plaque, as in the carotid arteries. However, cerebrovascular accidents (CVAs) are often associated with the rupture of unstable plaques located in regions with a non-significant degree of luminal stenosis. Thus up to 50% of high-risk atherosclerotic plaques may go undetected and untreated. Plaque composition is an additional and perhaps, more important risk factor for CVA rather than stenosis severity alone. Accurate identification of these high-risk, rupture-prone plaques may potentially prevent CVAs in a significant number of patients.
The data collected during this study (ultrasonic backscatter and histologically processed carotid plaque) will provide the basis for a novel algorithm to add plaque composition information to the plaque size and location information that is currently provided by standard ultrasound imaging. The input parameters for the algorithm are derived from two types of non-invasive ultrasound data: spectral parameters and acoustic radiation force impulse (ARFI) data. Spectral parameters are extracted from the frequency content of the backscattered diagnostic ultrasound signals. These are the same signals currently used for imaging, however, imaging relies solely on the strength of the signal to form the image and ignores the spectral information. Thus spectral analysis is an approach to use the information which is sensitive to the number and nature of the scatterers. In contrast ARFI techniques provide information on the stiffness of the tissue. ARFI is based on using a ultrasonic push pulse to slightly move the tissue (displacement on the order of microns) and an image of the relative displacements of the tissue (ARFI image) is created. The ARFI derived data and the spectral parameters will be combined with clinically available measures currently used for diagnosis of carotid stenosis to form the input parameters for the algorithm. In order to train and test the algorithm the plaque removed during surgery will be collected and the histology slides prepared from these plaques. This histology review provides the 'gold' standard for training and testing the algorithm. The majority of these matched sets (67%) will be used for training the algorithm. While the remainder (33%) will provide a test of the accuracy of the algorithm for these types of matched data. The sensitivity and specificity for each tissue type defined during the histology review will be reported.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Ohio
-
Cleveland、Ohio、アメリカ、44195
- Cleveland Clinic
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
CEA Cohort:
Inclusion Criteria:
- Age ≥40years
- Scheduled to undergo CEA for clinically significant carotid stenosis
- CEA is being performed for carotid stenosis of one or more of the following vessels: Internal Carotid Artery (ICA), distal end of the Common Carotid Artery (CCA), and/or CCA bulb.
Exclusion Criteria:
- Pregnancy
- Prior surgery or intervention involving the carotid artery
- Prior stent in the carotid artery
- Unable to provide informed consent
- CEA for carotid stenosis for proximal CCA only (ICA and distal CCA are not involved)
- CEA is scheduled for non-atherosclerotic vascular disease (e.g.,. fibromuscular dysplasia or systemic vasculitis)
- Unable to understand English language.
Normal Cohort:
Inclusion Criteria
- Age ≥40years
Exclusion Criteria
- Pregnancy
- Prior surgery or intervention involving the carotid artery (including CEA)
- Prior stent in the carotid artery
- Unable to provide informed consent
- Unable to understand English language.
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
CEA Group
Subjects with atherosclerotic stenosis of the carotid artery and are scheduled for a clinically indicated Carotid Endarterectomy (CEA) procedure to remove the atherosclerotic plaque.
Prior to CEA procedure, a research ultrasound exam will be performed.
The plaque tissue removed during the CEA will be collected and processed into histological slides.
|
Collection of backscattered ultrasound data during non-invasive ultrasound exam
|
|
Normal Group
Subjects who are not scheduled for a Carotid Endarterectomy (CEA) procedure and have had no prior carotid artery interventions.
Subjects will have a Research Ultrasound Exam performed.
|
Collection of backscattered ultrasound data during non-invasive ultrasound exam
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Classification Algorithm Error Rate
時間枠:Baseline
|
Classification of carotid artery plaque is produced by an algorithm that uses the QUS and ARFI derived parameters corresponding to a given region in the plaque to produce a classification of the plaque region into one of the following: calcium, fibrous, necrotic, or hemorrhagic.
Error rates from both the training and test data sets will be reported.
|
Baseline
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:D. Geoffrey Vince, PhD、The Cleveland Clinic
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- 12-797
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
Research Ultrasound Examの臨床試験
-
Abramson Cancer Center of the University of Pennsylvania完了
-
Sarasota Memorial Health Care System招待による登録
-
Teresa Moreno CasbasFondo de Investigacion Sanitaria完了
-
Cochlear完了